Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-053916
Filing Date
2009-03-13
Accepted
2009-03-13 16:41:50
Documents
18
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1291482
2 FORM OF EXECUTIVE OFFICER EMPLOYMENT AGREEMENT dex102.htm EX-10.2 49321
3 NALTREXONE HYDROCHLORIDE SUPPLY AGREEMENT dex1026.htm EX-10.26 161080
4 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 1552
5 SECTION 302 CERTIFICATION OF CEO dex311.htm EX-31.1 7870
6 SECTION 302 CERTIFICATION OF CFO dex312.htm EX-31.2 7868
7 SECTION 906 CERTIFICATION OF CEO AND CFO dex321.htm EX-32.1 7867
8 GRAPHIC g45071g11i41.jpg GRAPHIC 36266
9 GRAPHIC g45071g22q64.jpg GRAPHIC 32783
10 GRAPHIC g45071g31i25.jpg GRAPHIC 29784
11 GRAPHIC g45071g35z76.gif GRAPHIC 5023
12 GRAPHIC g45071g46f39.jpg GRAPHIC 33328
13 GRAPHIC g45071g50i83.jpg GRAPHIC 37157
14 GRAPHIC g45071g54b82.jpg GRAPHIC 28725
15 GRAPHIC g45071g56u98.jpg GRAPHIC 38540
16 GRAPHIC g45071g76i84.jpg GRAPHIC 29968
17 GRAPHIC g45071g91r90.jpg GRAPHIC 36312
18 GRAPHIC g45071g99m52.jpg GRAPHIC 35690
  Complete submission text file 0001193125-09-053916.txt   2003485
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

EIN.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-33415 | Film No.: 09680661
SIC: 2834 Pharmaceutical Preparations